| Literature DB >> 21375684 |
G Gonzalez1, Ss Park, Dw Chen, S Armitage, Ej Shpall, Rr Behringer.
Abstract
OBJECTIVES: The use of umbilical cord blood (CB) that is genetically resistant to HIV infection has been proposed as a novel stem cell therapy for the treatment of patients with AIDS. These genetically unique CB units (CBUs) should be present in public CB banks at a predicted frequency.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21375684 PMCID: PMC4021858 DOI: 10.1111/j.1468-1293.2010.00911.x
Source DB: PubMed Journal: HIV Med ISSN: 1464-2662 Impact factor: 3.180